GPGláucia Paranhos-Baccalà

Gláucia Paranhos-Baccalà

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Gláucia Paranhos-Baccalà has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Wu

    Christophe Mérieux Laboratory, IPB, CAMS-Fondation Mérieux, Institute of Pathogen Biology, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100730, China

    1 shared publication
  • Guilan Lu

    Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control, Beijing, 100013, China.

    1 shared publication
  • Guy Vernet

    Fondation Mérieux, Lyon, France

    1 shared publication
  • Jiang Wu

    Institute of Immunization and Prevention of Beijing Center for Disease Prevention and Control, 16, Hepingli Middle Avenue, Dongcheng District, Beijing 100013, China

    1 shared publication
  • Jianwei Wang

    NHC Key Laboratory of System Biology of Pathogens and Christophe Mérieux Laboratory, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College

    1 shared publication
  • Li Guo

    NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory Chinese Academy of Medical Sciences & Peking Union Medical College National Institute of Pathogen Biology Beijing People's Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China

    by Guilan Lu, Richard Gonzalez, Li Guo, Chao Wu, Jiang Wu, Guy Vernet, Gláucia Paranhos-Baccalà, Jianwei Wang, Tao Hung

    Background: Human metapneumovirus (hMPV), a recently identified virus, causes acute respiratory tract infections (ARTIs) in infants and children. However, studies on the seroepidemeology of hMPV are very limited in China. To assess the seroprevalence of hMPV infection in China, we tested a total of 1,156 serum specimens for the presence of anti-hMPV IgG antibody in children and adults free of acute respiratory illness in Beijing, China by using hMPV nucleocapsid (N) protein as an antigen. As a control, we used the human serum antibody against the N protein of human respiratory syncytial virus (hRSV), the most important viral agent responsible for ARIs in children. Results: The seropositive rate for hMPV increased steadily with age from 67% at 1-6 mo to 100% at age 20. However, the rate dropped slightly between 6 mo and 1 yr of age. The seropositive rate for hRSV also increased steadily with age from 71% at 1-6 mo to 100% at age 20. In children aged six months to six years, the seropositive rates for the anti-hRSV IgG antibody were significantly higher than those for hMPV. Additionally, IgG antibody titers to hMPV and hRSV were significantly higher in adults than in young children. Consistent with the seropositive rates, the geometric mean titer of anti-hMPV IgG antibody was lower than that of anti-hRSV IgG antibody in children aged six months to six years. Conclusions: Our results indicate that similar to hRSV, exposure to hMPV is ubiquitous in the Beijing population. However, the seroprevalence of anti-hMPV IgG antibody is lower than that of hRSV in children between six months and six years old, which suggests a different number of repeat infections or a different response to infections.